000 | 01920 a2200517 4500 | ||
---|---|---|---|
005 | 20250514221945.0 | ||
264 | 0 | _c20050503 | |
008 | 200505s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm049483y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOjima, Iwao | |
245 | 0 | 0 |
_aDesign, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cMar 2005 |
||
300 |
_a2218-28 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xmetabolism |
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCombinatorial Chemistry Techniques |
650 | 0 | 4 |
_aDrug Resistance, Multiple _xdrug effects |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrophobic and Hydrophilic Interactions |
650 | 0 | 4 |
_aMitoxantrone _xmetabolism |
650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xmetabolism |
650 | 0 | 4 |
_aPaclitaxel _xpharmacology |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aTaxoids _xchemical synthesis |
700 | 1 | _aBorella, Christopher P | |
700 | 1 | _aWu, Xinyuan | |
700 | 1 | _aBounaud, Pierre-Yves | |
700 | 1 | _aOderda, Cecilia Fumero | |
700 | 1 | _aSturm, Matthew | |
700 | 1 | _aMiller, Michael L | |
700 | 1 | _aChakravarty, Subrata | |
700 | 1 | _aChen, Jin | |
700 | 1 | _aHuang, Qing | |
700 | 1 | _aPera, Paula | |
700 | 1 | _aBrooks, Tracy A | |
700 | 1 | _aBaer, Maria R | |
700 | 1 | _aBernacki, Ralph J | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 48 _gno. 6 _gp. 2218-28 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm049483y _zAvailable from publisher's website |
999 |
_c15443861 _d15443861 |